Gateway Investment Advisers LLC Increases Position in Teleflex Incorporated (NYSE:TFX)

Gateway Investment Advisers LLC increased its stake in Teleflex Incorporated (NYSE:TFX) by 58.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 29,084 shares of the medical technology company’s stock after purchasing an additional 10,729 shares during the quarter. Gateway Investment Advisers LLC owned approximately 0.06% of Teleflex worth $7,237,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Atlanta Capital Management Co. L L C raised its holdings in shares of Teleflex by 2.6% in the 2nd quarter. Atlanta Capital Management Co. L L C now owns 2,519,464 shares of the medical technology company’s stock worth $523,444,000 after purchasing an additional 64,985 shares during the period. Janus Henderson Group PLC grew its stake in Teleflex by 50,429.2% in the 2nd quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock valued at $377,296,000 after buying an additional 1,812,426 shares in the last quarter. State Street Corp grew its stake in Teleflex by 1.8% in the 2nd quarter. State Street Corp now owns 1,399,922 shares of the medical technology company’s stock valued at $290,853,000 after buying an additional 25,401 shares in the last quarter. American Century Companies Inc. grew its stake in Teleflex by 41.6% in the 3rd quarter. American Century Companies Inc. now owns 1,187,909 shares of the medical technology company’s stock valued at $287,438,000 after buying an additional 348,829 shares in the last quarter. Finally, Koch Industries Inc. grew its stake in Teleflex by 47,174.3% in the 2nd quarter. Koch Industries Inc. now owns 959,669 shares of the medical technology company’s stock valued at $955,000 after buying an additional 957,639 shares in the last quarter. 89.22% of the stock is currently owned by institutional investors.

In related news, Director George Babich, Jr. sold 2,500 shares of the company’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $283.11, for a total value of $707,775.00. Following the completion of the transaction, the director now directly owns 9,581 shares in the company, valued at $2,712,476.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $276.44, for a total transaction of $55,288.00. Following the completion of the transaction, the director now owns 8,080 shares of the company’s stock, valued at $2,233,635.20. The disclosure for this sale can be found here. Insiders have sold a total of 7,600 shares of company stock valued at $2,040,569 over the last 90 days. Company insiders own 2.39% of the company’s stock.

A number of research analysts recently weighed in on the stock. Leerink Swann reiterated a “buy” rating and issued a $321.00 price objective (up from $307.00) on shares of Teleflex in a research note on Tuesday, January 30th. Stephens reiterated a “buy” rating and issued a $300.00 price objective on shares of Teleflex in a research note on Thursday, January 18th. ValuEngine lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Morgan Stanley lifted their price objective on shares of Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research note on Friday, November 3rd. Finally, Jefferies Group lifted their price objective on shares of Teleflex from $270.00 to $295.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. One analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $283.89.

Teleflex Incorporated (TFX) traded up $2.45 on Monday, hitting $255.20. 225,341 shares of the stock were exchanged, compared to its average volume of 290,546. The stock has a market cap of $11,386.20, a price-to-earnings ratio of 46.57, a P/E/G ratio of 1.86 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.72 and a quick ratio of 3.70. Teleflex Incorporated has a 12-month low of $173.91 and a 12-month high of $288.78.

TRADEMARK VIOLATION WARNING: “Gateway Investment Advisers LLC Increases Position in Teleflex Incorporated (NYSE:TFX)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/12/teleflex-incorporated-tfx-holdings-increased-by-gateway-investment-advisers-llc.html.

Teleflex Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply